Skip to main content

Table 6 Cohort studies of patients with renal infarction

From: Renal arteriography with endovascular ultrasound for the management of renal infarction patients

Study (number of patients) Period of inclusion Mean age (Years) History of atrial fibrillation (%) ESRD All-cause mortality rate Recurrence of thromboembolic event Antithrombotic secondary prevention treatment
anticoagulant alone antiplatelet alone anticoagulant and antiplatelet
Bourgaultet al. [10] 1989–2011 53 18 5% at 30 days 0% at 30 days 38 35 0
Huanget al. [3] 1991–2016 56 56 7%bat 48 months 30% at 48 months 12% at 48 months 44 0 0
Ohet al. [15] 1993–2013 60 45 2,1% at 20 months 5% at 20 months 2,8 48,2 37,2 14
Baeet al. [12] 1995–2012 59 40 70 6 0
Mesianoet al. [13] 1999–2015 59,8 28 5.6% at 15 months 44 33 0
Rheeet al. [1] 2000–2009 56 25 19,7% at 40 months
Fauconet al. [11]
2000–2015
53 4
Yun [2] 2006–2012 61,3 53 2% at 41 months 36% at 5 yearsa 19% at 20 months 100 (for 3–6 months and lifelong if indication) 0 0
Cerba et al. [14] 2013–2015 57 0% at 6 months 9% at 6 months 0 at 6 months 64 36 0,9
Erenet al. [16] 2015–2018 53 30 3% at 14 months 5% at 14 months 41 0
  1. Studies written in bold were prospective
  2. adialysis-free survival at 5 years: 64%. b: 5 patients on 70
  3. ESRD End-stage renal disease
\